Humoral Response to mRNA versus an Adenovirus Vector-Based SARS-CoV-2 Vaccine in Dialysis Patients

Authors :: Linda H. Ficociello
Ines A. Dahne-Steuber
Michael S. Anger
Ruchir Patel
Robert J. Kossmann
Amit Fadia
Josephine DeLisi
Jeffrey Hymes
Claudy Mullon
Melanie C. Pollan
Curtis Johnson
Joanna Willetts
Chance Mysayphonh
Jeffrey G. Mulhern
Source :: Clin J Am Soc Nephrol
Publication Year :: 2021
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2021.
Abstract: Patients on maintenance dialysis may be immunocompromised and have comorbidities that modulate the response to coronavirus disease 2019 (COVID-19) vaccines. We conducted a quality improvement project to characterize the antibody response to COVID-19 vaccination in two dialysis clinics in Arizona

Tools